(19)
(11) EP 3 240 596 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.11.2020 Bulletin 2020/47

(45) Mention of the grant of the patent:
09.09.2020 Bulletin 2020/37

(21) Application number: 15830933.6

(22) Date of filing: 22.12.2015
(51) International Patent Classification (IPC): 
A61M 5/315(2006.01)
A61M 5/28(2006.01)
A61M 5/31(2006.01)
 A61J 1/20(2006.01)
A61M 5/24(2006.01)
(86) International application number:
PCT/US2015/067379
(87) International publication number:
WO 2016/109339 (07.07.2016 Gazette 2016/27)

(54)

CONTAINER FOR MIXING AND DISPENSING FLUID MEDICATION COMPONENTS

BEHÄLTER ZUM MISCHEN UND VERABREICHEN VON FLUIDEN ARZNEIMITTELKOMPONENTEN

RÉSERVOIR POUR MÉLANGER ET DISPENSER DES COMPOSANTES DE MÉDICAMENT FLUIDES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 30.12.2014 US 201462098079 P

(43) Date of publication of application:
08.11.2017 Bulletin 2017/45

(73) Proprietor: Kindeva Drug Delivery L.P.
St. Paul, MN 55170 (US)

(72) Inventors:
  • EGELAND, Marc A.
    Saint Paul, Minnesota 55133-3427 (US)
  • NG, Chin-Yee
    Saint Paul, Minnesota 55133-3427 (US)
  • ETTER, Jo A.
    Saint Paul, Minnesota 55133-3427 (US)
  • KOLAKALURI, Ravi
    Saint Paul, Minnesota 55133-3427 (US)

(74) Representative: Isarpatent 
Patent- und Rechtsanwälte Behnisch Barth Charles Hassa Peckmann & Partner mbB Friedrichstrasse 31
80801 München
80801 München (DE)


(56) References cited: : 
EP-A1- 0 172 990
EP-A2- 0 664 136
WO-A1-2008/150208
JP-A- 2005 185 747
 EP-A1- 1 728 528
EP-A2- 0 815 886
CA-C- 2 016 870
US-A1- 2008 045 889
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).